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C-terminal rearrangement ions [bn-1 1 H2O] (where n refers to the total number of residues of
peptides) are frequently observed for peptides which contain basic amino acid(s), especially
arginine, at or near their N termini in low- and high-energy collision-induced dissociation or
post-source decay (PSD) spectra. Here we report a novel rearrangement, associated with PSD
for serine- or threonine-containing peptides that are susceptible to C-terminal rearrangement.
Based on PSD analyses of serine- or threonine-containing bradykinin and its analogs, which
have been ethyl-esterified or 18O labeled at their C termini, the [bk 1 H2O] (where k denotes
the position adjacent to the left of the Ser/Thr residue) ion is generally thought to be formed
by the transfer of the hydroxyl moiety of a serine or threonine residue to the carbonyl group
of the residue to its left accompanied by the loss of the remaining C-terminal portion of the
peptide. When the Ser/Thr is at or near the C terminus, the present [bk 1 H2O] ion could be
formed via two pathways, i.e., the Ser/Thr-related rearrangement and the conventional
C-terminal rearrangement, which has been clearly verified by 18O labeling at the C terminus.
In addition, the ions which are formally designated as [ymbl 1 H2O], where ymbl denotes a
b-type internal ion, are also briefly described. (J Am Soc Mass Spectrom 2000, 11,
345–351) © 2000 American Society for Mass Spectrometry
The combination of electrospray ionization (ESI)[1], matrix-assisted laser desorption/ionization(MALDI) [2], and related ionization techniques
[3] with tandem mass spectrometry (MS/MS) or multi-
ple-stage tandem mass spectrometry (MSn) has made
significant contributions to the structural characteriza-
tion of peptides and other biologically important mol-
ecules [4–8]. In MS/MS analyses of peptides, the prod-
uct ions, which are of considerable structural value, and
which are often dominated by backbone fragmented
ions (designated, according to Biemann’s nomenclature
[9], as a-, b-, or c-type ions for charge retention on the
N-terminal fragment and x-, y-, or z-type ions for
charge retention on the C-terminal fragment), are pro-
duced under conditions of high- or low-energy colli-
sion-induced dissociation (CID) or metastable decom-
position such as MALDI post-source decay (PSD). This
process allows a satisfactory identification of peptides
or de novo sequencing. However, the possibility of
fragmentation at a variety of sites on a peptide often
complicates the assignments [10–19], especially under
high-energy CID conditions. It might be possible to
circumvent this issue by using a low-energy MS/MS or
MALDI-PSD technique since the b- and y-type ions of
peptides and their decomposition products, such as
b-17, b-18, and y-17, etc. are the major products in the
spectra. Derivatization [20–24], and other chemical ma-
nipulations such as isotopic labeling [7, 25–27], can also
simplify the spectra considerably. It is clear, however,
that a sustained investigation of the novel fragmenta-
tion of peptides is also important, in order to structur-
ally characterize peptides by tandem mass spectrome-
try more effectively.
The mode of internal fragmentation, which involves
the loss of the C-terminal amino acid via the transfer of
a C-terminal hydroxyl moiety to the carbonyl group of
the penultimate amino acid residue, has been exten-
sively studied for metal cationized [28–32] or proton-
ated peptides [33–36] by fast atom bombardment (FAB)
tandem mass spectrometry. The resulting product ion,
which is formally designated as [bn-1 1 cation 1 OH] or
[bn-1 1 H2O], respectively, according to Biemann’s modi-
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fied nomenclature, has been extensively investigated by
Gross’s group [30] for metal cationized peptides and
Gaskell’s group [33–35] for protonated peptides labeled
with 18O at their C termini by acid-catalyzed solvent
isotope exchange. The effect of the presence of basic
amino acids on this fragmentation has also been exam-
ined by our group [36]. In the present study, we wish to
report a novel type of rearrangement, specifically ob-
served for protonated serine- or threonine-containing
peptides, which could give rise to the formally classi-
fied [bk 1 H2O] (k refers to the position adjacent to the
left of the Ser/Thr residue). In addition, another type of
fragmentation which is responsible for the formation of
the [ymbl 1 H2O] ion, is also discussed briefly.
Experimental
The peptides bradykinin, des-Arg9-bradykinin, des-
Pro2-bradykinin, and lysyl-bradykinin were purchased
from the Peptide Institute (Minoh-Shi, Osaka, Japan).
Figure 1. Partial PSD spectra of (a) bradykinin, (b) ethyl esterified bradykinin, and (c) synthetic
peptide 8 (RPPGFAPFR). Peaks labeled with asterisks in (c) denote internal ions.
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a-Cyano-4-hydroxycinnamic acid (a-CHCA) (the
MALDI matrix material) was purchased from Sigma
Chemical (St. Louis, MO). 18O-normalized water (94%)
was purchased from ISOTEC (Miamisburg, OH). All
the synthetic peptides used in this study were prepared
on a 9050 Peptide Synthesizer (PE Biosystems, Framing-
ham, MA). All other reagents were of guaranteed grade
from Nacalai Tesque (Kyoto, Japan) and were used
without further purification.
Some of the peptides used in this study were labeled
at their C termini with 18O by acid catalyzed isotopic
exchange. Approximately 1 nmol of each peptide was
dissolved in 25 mL of [18O] water. Hydrochloric acid (12
M, 1 mL) was added to each sample, and the mixtures
were allowed to stand at 37 °C for 72 h. A portion (1 mL)
of each final solution was subjected to PSD analysis.
The ethyl esters of some peptides studied were
prepared by acid-catalyzed esterification. Each peptide
(1 nmol) was dissolved in a solution composed of 50 mL
ethanol and 5 mL hydrochloric acid (12 M) in a 0.5-mL
polypropylene Assist tube (Assist Trading, Tokyo, Ja-
pan). After vortexing and centrifugation, each sample
was maintained at 50 °C for 2 h. The resulting solution
(1 mL) was then directly subjected to MALDI-PSD
analysis.
A positive-ion PSD MALDI-TOFMS was performed
with a Voyager Elite XL time-of-flight mass spectrom-
eter equipped with a delayed-extraction system (PE
Biosystems, Framingham, MA) with flight paths of
6.5 m for the reflectron mode. The peptide-containing
solution (1 mL) was mixed with the matrix solution, the
supernatant of a 50% aqueous acetonitrile solution
saturated with a-CHCA, and the resulting solution was
air dried on the flat surface of a stainless-steel plate. The
ions were generated by irradiation with a N2 laser at a
wavelength of 337 nm, and accelerated at 20 kV poten-
tial in the ion source with a delay of 100 ns in the PSD
mode. Calibrations were carried out using angiotensin I
and applied to all measurements in this study.
Results and Discussion
The PSD spectrum of [M 1 H]1 ions derived from
bradykinin (Arg-Pro-Pro-Gly-Phe-Ser-Pro-Phe-Arg)
showed a prominent rearranged ion at m/z 904.7 (data
not shown), which had been verified to be attributed
almost entirely to the “C-terminal rearrangement” [34]
using an 18O-labeling approach, and was designated as
[bn-1 1 H2O] ion (in this case [b8 1 H2O]). Figure 1a
shows the partial PSD spectrum of the protonated
bradykinin. One unidentified fragment ion at m/z 573.5
was clearly observed, which could also be rationalized
as an [b5 1 H2O] type and could not be directly ac-
counted for by the conventional “C-terminal rearrange-
ment.” Although an earlier study [34, 35] suggested that
the [bn-1 1 H2O] ion might be amenable to a second
rearrangement at the newly formed C terminus, gener-
ating a [bn22 1 H2O] ion, and subsequently, the third
stage of a rearrangement can give the [bn23 1 H2O] ion,
albeit with a reduced abundance, the present [b5 1
H2O] ion, which is observed with appreciably relative
abundance, is unlikely to originate from this C-terminal
rearrangement because the b5 position is clearly too far
removed from the C terminus to be involved in a
fourth-stage C-terminal rearrangement.
To examine whether or not this [b5 1 H2O] ion is
produced via the C-terminal rearrangement, bradykinin
was ethyl esterified at the C terminus and then ana-
lyzed by MALDI-PSD. Part of the corresponding spec-
trum is shown in Figure 1b. Surprisingly, the signal at
m/z 573.4 became the base peak of the spectrum, sug-
gesting that it had not originated from the C-terminal
rearrangement because the C-terminal carboxyl group
was ethyl esterified. Therefore some other mechanism
must be responsible for the production of this [b5 1
Scheme 1. Proposed mechanism for the formation of the [bk 1
H2O] ions under MALDI-PSD.
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H2O] ion. We are proposing that the hydroxyl group of
a serine residue at the neighboring site of the b5 ion
could be specifically involved in the formation of this
ion. To confirm this, the peptide (Arg-Pro-Pro-Gly-Phe-
Ala-Pro-Phe-Arg) was synthesized and analyzed by
PSD (Figure 1c). This peptide represents a bradykinin in
which the serine (S) residue is replaced by an alanine
(A) residue. As a result, in contrast to Figure 1a, the
[b5 1 H2O] ion signal was almost completely sup-
pressed, providing convincing support for the above
proposal. It should be pointed that such a rearranged
ion was also observed by PSD for a peptide (synthetic
peptide 1) containing a threonine residue instead of a
serine residue (see below). The proposed mechanism
for the formation of such types of ions is shown in
Scheme 1, and is based on the analogy of those pro-
posed for the formation of the [bn-1 1 H2O] ions de-
rived from metal cationized [30] and protonated pep-
tides [34, 35] in previous studies.
Although the PSD experiment involving bradykinin
verified that the [bk 1 H2O] ([b5 1 H2O] in Fig. 1) ion
was produced via the Ser/Thr-related rearrangement, it
is also possible that it is derived from the C-terminal
rearrangement when the serine or threonine residue is
at or near the C termini of peptides. As a typical
example, Figure 2 shows the PSD spectrum of synthetic
peptide 3 (Arg-Pro-Pro-Gly-Phe-Ser-Arg) with and
without 18O labeling. It is noteworthy that the [b5 1
H2O] ion at m/z 573.3 in Figure 2a, which should have
the same structure as that observed for bradykinin, fell
into two types of isotopic ions after 18O labeling, i.e., a
[b5 1 H2O] ion at m/z 573.3 and a [b5 1 H2
18O] ion at
m/z 575.3 (Figure 2b). According to Ballard’s work [35]
with respect to the [18O2]-labeled peptides, the [bn-1 1
H2
18O] ion formed after one C-terminal rearrangement
would be expected to give rise to both unlabeled and
[18O1]-labeled [bn-2 1 H2O] ions at a ratio of 1:1 in the
absence of an isotope effect, while, in fact, the ratio was
generally distorted in favor of the production of the
[18O1]-labeled species. It should be pointed that this
phenomenon could also be followed by MALDI-PSD, as
typically demonstrated for [18O2]-labeled peptide 9
Figure 2. Partial PSD spectra of synthetic peptide 3 (RPPGFSR): (a) ordinary peptide and (b)
[18O2]-labeled one. The inset in (b) shows the partial PSD spectrum of [
18O2]-labeled synthetic peptide
9 (RPPGFFR). Peaks labeled with asterisks refer to unassigned peaks.
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(Arg-Pro-Pro-Gly-Phe-Phe-Arg) in the inset of Figure
2b, where a [b5 1 H2
18O] (corresponding to the [bn-2 1
H2O] ion) ion at m/z 575.5 was observed with a slightly
higher intensity than the [b5 1 H2O] ion. For the case of
the present peptide, however, the rearranged ion which
corresponds to a [bn-2 1 H2O] ion, gave a peak intensity
ratio of [b5 1 H2O] to [b5 1 H2
18O] ion different from
the general case, i.e., the [b5 1 H2O] ion was more
abundant than the [b5 1 H2
18O] ion. Thus it is most
likely that the peak of the [b5 1 H2O] ion in Figure 2a
was produced via two discrete formation mechanisms,
one involving the C-terminal rearrangement, and the
other, the Ser/Thr-related rearrangement, because this
peptide has the potential to rearrange at the penulti-
mate serine position from the C terminus. The related
results from the PSD analyses of bradykinin and its
analogs are summarized in Table 1. It can be rational-
ized from Table 1 that, the [bk 1 H2O] ions, where k is
the position adjacent to the left of a Ser/Thr residue,
could be formed via both the Ser/Thr-related rear-
rangement and the “C-terminal rearrangement” when
k $ n23, and would be formed only from the Ser/Thr-
related rearrangement when k # n24 under conditions
of metastable decomposition.
During the investigation of the Ser/Thr-related rear-
rangement based on the PSD analyses of bradykinin
and its analogs that are amenable to the C-terminal
rearrangement, another novel kind of fragmentation,
which is thought to be related to the C-terminal rear-
rangement, was observed. Figure 3 shows the partial
PSD spectrum of a synthetic peptide (Arg-Pro-Pro-Gly-
Phe-Phe-Arg), which is dominated by the backbone-
fragmented ions (a-, b-, or y-type ions) and their
decomposition or rearrangement products. Three pairs
of internal ions which correspond to b-type (ymbl) and
a-type (ymal) ions were also produced. In addition,
three unknown but reasonably abundant peaks
(marked with asterisks) whose masses were 18 units
higher than those of their corresponding ymbl ions were
also observed in this spectrum. They were formally
designated as [ymbl 1 H2O] ions. The PSD spectrum of
the present peptide in which the C-terminal residue
was 18O labeled on the carboxyl group revealed that
origin of the C-terminal hydroxyl groups of these ions
Table 1. [bl 1 H2O] (including [bk 1 H2O]) ions observed for bradykinin and its analogs under MALDI-PSD
Peptide Sequence Derivatives [M 1 H]1 m/z [bl 1 H2O] l [bl 1 H2
18O] l
Bradykinin RPPGF/SPFR — 1060.6 5, 6, 7, 8c —
[18O2]
a 1064.6 5, 6, 7 7, 8
Ethyl esterb 1088.6 5 —
Synthetic peptide 1 RPGF/TPFR — 977.5 4, 5, 6, 7 —
[18O2] 981.5 4, 5, 6 6, 7
Ethyl ester 1005.6 4 —
Des-Arg9-bradykinin RPPGF/SPF — 904.5 5, 6, 7 —
Ethyl ester 932.5 5 —
Des-Pro2-bradykinin RPGF/SPFR — 963.5 4, 5, 6, 7 —
[18O2] 967.5 4, 5, 6 6, 7
Ethyl ester 991.5 4 —
Lysyl-bradykinin KRPPGF/SPFR — 1188.7 6, 7, 8, 9 —
[18O2] 1192.7 6, 7, 8 8, 9
Ethyl ester 1216.7 6 —
Synthetic peptide 2 RPPGF/SFR — 963.5 5, 6, 7 —
Ethyl ester 991.5 5 —
Synthetic peptide 3 RPPGF/SR — 816.4 5d, 6 —
[18O2] 820.4 5
d 5, 6
Ethyl ester 844.4 5 —
Synthetic peptide 4 RAA/SGAR — 688.4 3, 4, 5, 6 —
[18O2] 692.4 3, 4, 5 5, 6
Ethyl ester 716.4 3 —
Synthetic peptide 5 PPGF/SPFR — 904.5 n.d.e —
Synthetic peptide 6 APPGF/SFR — 878.5 n.d. —
Synthetic peptide 7 APPGF/SR — 731.4 n.d. —
Synthetic peptide 8 RPPGFAPFR — 1044.6 7, 8 —
Synthetic peptide 9 RPPGFFR — 876.5 4, 5, 6 —
[18O2] 880.5 4, 5 5, 6
Synthetic peptide 10 RPPGFR — 729.4 4, 5 —
[18O2] 733.4 4 4, 5
a[18O2] labeling at the C-terminal carboxyl group.
bEthyl esterified at the C termini.
cIndicating that the [bl 1 H2O] (l 5 5– 8) ions were observed in the spectrum. The underlined numbers refer to the [bk 1 H2O] ion, where k denotes
the position adjacent to the left of the Ser/Thr residues of peptides.
dAlso including the contribution of C-terminal rearrangement.
en.d., not detected.
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was the original C-terminal carboxyl group (as could be
partially verified by the peak of m/z 566.5 in the inset of
Figure 2b). Thus, it is likely that they were either
formed via the cleavage of an N-terminal residue from
a [bl 1 H2O] (including [bn-1 1 H2O]) ion, or formed
from the corresponding ym ion followed by a C-termi-
nal rearrangement. The existence of considerable
amounts of such [ymbl 1 H2O] ions in the PSD spectra
of other peptides containing Arg at or near the N
termini suggests the need for caution in the peak
assignments by MALDI-PSD.
Conclusion
In this study, two novel types of fragment ions, for-
mally classified as [bk 1 H2O] and [ymbl 1 H2O] ions,
produced by metastable decomposition in MALDI-TOF
mass spectrometry, were investigated. These types of
ions were specifically observed for protonated peptides
that are amenable to the C-terminal rearrangement, i.e.,
those which contain a basic amino acid (especially Arg)
in the N-terminal region. It should be noted that these
ions are barely observed under low-energy CID but
appear in appreciable abundance in PSD.
Unlike the [bn-1 1 H2O] ion produced by the C-
terminal rearrangement, the present [bk 1 H2O] ion is
formed at the vicinal position of Ser/Thr via a rear-
rangement involving the transfer of a hydroxyl group of
Ser/Thr to the carbonyl group of the neighboring
residue. In addition, ethyl esterification greatly in-
creased the relative abundance of the [bk 1 H2O] ion
(for example, the [b5 1 H2O] in Figure 1b), in part,
because esterification eliminated the negative charge on
the carboxyl group, rendering the peptide conformation
different from the native one in the gas phase, due to
the loss of a salt bridge between the carboxyl anion and
a positively charged site, most probably, the guanidyl
group of an Arg residue. In spite of the limited inves-
tigation of the present metastable ions, they appear to
have potential value in the area of de novo peptide
sequencing or database searching.
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